|
|
||||||||
1 Department of Biochemistry and Biophysics and
2 Department of Medical Biochemistry and Genetics, Center for Advanced Biomolecular Research, Texas A&M University, College Station, Texas 77843-1114, USA
Reprint requests to: J. Martin Scholtz, Department of Biochemistry and Biophysics, Center for Advanced Biomolecular Research, Texas A&M University, College Station, TX 77843-1114, USA; e-mail: jm-scholtz{at}tamu.edu; fax: (979) 847-9481.
(RECEIVED April 21, 2003; FINAL REVISION July 3, 2003; ACCEPTED July 7, 2003)
Supplemental material: See www.proteinscience.org
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.03152903.
| Abstract |
|---|
|
|
|---|
Keywords: Amyloid; amyloid fibrils; pI; protein solubility; protein stability
| Introduction |
|---|
|
|
|---|
Recently, proteins such as human muscle acylphosphatase, hen egg white lysozyme, the B1 binding domain of protein G, the SH3 domain of PI3, and myglobin have been shown to form fibrils in vitro (Chiti et al. 1999; Krebs et al. 2000; Ramirez-Alvarado et al. 2000; Fändrich et al. 2001). These fibrils show ultrastructure and dye-binding characteristics identical to fibrils formed from the disease-causing proteins (Wetzel 2002). In most cases, fibrils were obtained from solution conditions where the native conformation was destabilized by pH, temperature, and/or the addition of cosolvents like alcohols, salts, or metal ions. These results suggest that the ability of a protein to form fibrils in vitro depends upon the conformational stability of the protein, defined as the difference in free energy (
G) between the folded and unfolded conformations (Kelly 1996; Chiti et al. 1999, 2000; Ramirez-Alvarado et al. 2000). It further implies that as proteins are destabilized, either through alterations in amino acid sequence or changes in the solutions conditions, the formation of amyloid fibril is enhanced. Here, we wish to expand these conclusions to include the idea that the solubility of the folded (or partially folded) conformation(s) of a protein is important, and perhaps the major factor in amyloid fibril formation.
A significant population of partially unfolded protein is likely necessary for fibril formation to occur in many of the proteins studied to date (Chiti et al. 1999, 2000; Ramirez-Alvarado et al. 2000; Khurana et al. 2001a,b; Taddei et al. 2001). For example, fibrils of acylphosphatase fibrils are formed in mixtures of water and 2,2,2-trifluoroethanol (TFE), an organic solvent that has been shown to promote secondary structure formation at low concentrations. Because TFE is known to increase the solubility of hydrophobic groups while decreasing the solubility of peptide groups (Luo and Baldwin 1997; Buck 1998), structures that have exposed hydrophobic groups and buried peptide groups are favored. Other studies of fibril formation with transthyretin (TTR; Jiang et al. 2001), human lysozyme (Pepys et al. 1993), the light chain of IgG (Souillac et al. 2002), methionine aminopeptidase (Nielsen et al. 2001), and fibronectin (Litvinovich et al. 1998) emphasize that conditions that favor partial unfolding of the protein can significantly enhance fibril formation. Together, these results also support the hypothesis that any protein can form amyloid under certain conditions, and fibril formation is accelerated when the conditions favor partial unfolding of the native conformation (Dobson 1999).
Although protein stability is certainly important for fibril formation, the association between protein solubility and fibril formation has not been directly correlated. The solubility of globular proteins is determined by the amino acid content, the pK values of the ionizable residues, and environmental factors such as temperature, pH, and the presence of cosolvents (Schein 1990). Proteins and polypeptides are generally least soluble at pH values near their isoelectric point (pI), where the overall net charge is zero (Riès-Kraut and Ducruix 1997).
The purpose of this study is to investigate the relationship between stability, solubility, and fibril formation using ribonuclease Sa (RNase Sa) from Streptomyces aureofaciens as a model system. RNase Sa is a small acidic protein (96 residues, pI = 3.5) with a mixed
+ ß structure. There are no lysine residues, and the protein contains a single disulfide bond (Shaw et al. 2001). We have recently made variants that replaced solvent-exposed acidic residues with lysine residues (Shaw et al. 2001). The mutant with three such charge reversals is denoted 3K, and that with five charge reversals is 5K. By reversing the charge at these sites, we have changed the pI of RNase Sa from 3.5 to 6.4 (3K) or 10.2 (5K; Shaw et al. 2001). Thus, we are able, here, to study the relationship between stability, solubility, and fibril formation in a single protein over an exceptionally wide pH range.
| Results and Discussion |
|---|
|
|
|---|
|
15- to 20-fold from 10% TFE to 35% TFE. Above 35% TFE, ThT fluorescence drops markedly, and CD spectra of the samples show a change from predominantly ß-structure to substantial
-helical structure (data not shown). This change in secondary structure at high TFE concentrations has also been observed with other proteins (Chiti et al. 2000).
|
The results shown in Figure 2
led us to study the effects of pH on fibril formation with our charge-reversal variants. RNase Sa, 3K, and 5K were incubated in solutions of 30% TFE ranging in pH from 2 to 9.6. Figure 3
shows the correlation between fibril formation, conformational stability, and solubility for these proteins as a function of pH. All three variants are maximally stable near pH 5, but the minimum solubility of the proteins shifts with their pI, from near pH 3.5 for RNase Sa to pH > 9 for the 5K variant (Shaw et al. 2001). Fibril formation is most prominent at the pH where solubilty is minimal, that is, near the pI of the protein. These results show that fibril formation correlates with the pH-dependence of the protein solubility and not with conformational stability for all these RNase Sa variants. These results very strongly show that protein solubility is a major factor in fibril formation.
|
-synuclein, transthyretin, and the Aß peptide are especially significant, since these proteins are known to form amyloid fibrils in vivo (Wood et al. 1996; Jiang et al. 2001; Hoyer et al. 2002).
|
|
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., and Dobson, C.M. 1999. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. 96: 35903594.
Chiti, F., Taddei, N., Bucciantini, M., White, P., Ramponi, G., and Dobson, C.M. 2000. Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J. 19: 14411449.[CrossRef][Medline]
Cohen, A.S. 1967a. Amyloidosis. N. Engl. J. Med. 277: 522530.
. 1967b. Amyloidosis (concluded). N. Engl. J. Med. 277: 628638.
Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24: 329332.[CrossRef][Medline]
. 2001. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B 356: 133145.[CrossRef][Medline]
Fändrich, M., Fletcher, M.A., and Dobson, C.M. 2001. Amyloid fibrils from muscle myoglobin. Nature 410: 165166.[CrossRef][Medline]
Glenner, G.G. 1980a. Amyloid deposits and amyloidosis. The ß-fibrilloses (first of two parts). N. Engl. J. Med. 302: 12831292.[Medline]
. 1980b. Amyloid deposits and amyloidosis: The ß-fibrilloses (second of two parts). N. Engl. J. Med. 302: 13331343.[Medline]
Hebert, E.J., Grimsley, G.R., Hartley, R.W., Horn, G., Schell, D., Garcia, S., Both, V., Sevcik, J., and Pace, C.N. 1997. Purification of ribonucleases Sa, Sa2, and Sa3 after expression in Escherichia coli. Protein Expr. Purif. 11: 162168.[CrossRef][Medline]
Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T.M., and Subramaniam, V. 2002. Dependence of
-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322: 383393.[CrossRef][Medline]
Jiang, X., Smith, C.S., Petrassi, H.M., Hammarstrom, P., White, J.T., Sacchettini, J.C., and Kelly, J.W. 2001. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 40: 1144211452.[CrossRef][Medline]
Kallberg, Y., Gustafsson, M., Persson, B., Thyberg, J., and Johansson, J. 2001. Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276: 1294512950.
Kelly, J.W. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6: 1117.[CrossRef][Medline]
Khurana, R., Gillespie, J.R., Talapatra, A., Minert, L.J., Ionescu-Zanetti, C., Millett, I., and Fink, A.L. 2001a. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40: 35253535.[CrossRef][Medline]
Khurana, R., Uversky, V.N., Nielsen, L., and Fink, A.L. 2001b. Is Congo red an amyloid-specific dye? J. Biol. Chem. 276: 2271522721.
Krebs, M.R., Wilkins, D.K., Chung, E.W., Pitkeathly, M.C., Chamberlain, A.K., Zurdo, J., Robinson, C.V., and Dobson, C.M. 2000. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the ß-domain. J. Mol. Biol. 300: 541549.[CrossRef][Medline]
Lai, Z., Colon, W., and Kelly, J.W. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35: 64706482.[CrossRef][Medline]
Litvinovich, S.V., Brew, S.A., Aota, S., Akiyama, S.K., Haudenschild, C., and Ingham, K.C. 1998. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 280: 245258.[CrossRef][Medline]
Luo, P. and Baldwin, R.L. 1997. Mechanism of helix induction by trifluoroethanol: A framework for extrapolating the helix-forming properties of peptides from trifluoroethanol:water mixtures back to water. Biochemistry 36: 84138421.[CrossRef][Medline]
Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., Uversky, V.N., and Fink, A.L. 2001. Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry 40: 60366046.[CrossRef][Medline]
Pace, C.N., Laurents, D.V., and Thomson, J.A. 1990. pH dependence of the urea and guanidine hydrochloride denaturation of ribonuclease A and ribonuclease T1. Biochemistry 29: 25642572.[CrossRef][Medline]
Pace, C.N., Hebert, E.J., Shaw, K.L., Schell, D., Both, V., Krajcikova, D., Sevcik, J., Wilson, K.S., Dauter, Z., Hartley, R.W., et al. 1998. Conformational stability and thermodynamics of folding of ribonucleases Sa, Sa2 and Sa3. J. Mol. Biol. 279: 271286.[CrossRef][Medline]
Pepys, M.B., Hawkins, P.N., Booth, D.R., Vigushin, D.M., Tennent, G.A., Soutar, A.K., Totty, N., Nguyen, O., Blake, C.C., Terry, C.J., et al. 1993. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362: 553557.[CrossRef][Medline]
Pfeil, W. and Privalov, P.L. 1976. Thermodynamic investigations of proteins. I. Standard functions for proteins with lysozyme as an example. Biophys. Chem. 4: 2332.[CrossRef][Medline]
Ramirez-Alvarado, M., Merkel, J.S., and Regan, L. 2000. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. 97: 89798984.
Riès-Kraut, M. and Ducruix, A. 1997. Inferences drawn from physicochemical studies of crystallogenesis and precrystalline state. Methods Enzymol. 276: 2359.
Rochet, J.C. and Lansbury Jr., P.T. 2000. Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10: 6068.[CrossRef][Medline]
Schein, C.H. 1990. Solubility as a function of protein structure and solvent components. Biotechnology 8: 308317.[CrossRef][Medline]
Shaw, K.L., Grimsley, G.R., Yakovlev, G.I., Makarov, A.A., and Pace, C.N. 2001. The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci. 10: 12061215.
Souillac, P.O., Uversky, V.N., Millett, I.S., Khurana, R., Doniach, S., and Fink, A.L. 2002. Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH. J. Biol. Chem. 277: 1265712665.
Taddei, N., Capanni, C., Chiti, F., Stefani, M., Dobson, C.M., and Ramponi, G. 2001. Folding and aggregation are selectively influenced by the conformational preferences of the
-helices of muscle acylphosphatase. J. Biol. Chem. 276: 3714937154.
Wetzel, R. 2002. Ideas of order for amyloid fibril structure. Structure 10: 10311036.[Medline]
Wood, S.J., Maleeff, B., Hart, T., and Wetzel, R. 1996. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimers amyloid peptide Ab. J. Mol. Biol. 256: 870877.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Tjong and H.-X. Zhou Prediction of Protein Solubility from Calculation of Transfer Free Energy Biophys. J., September 15, 2008; 95(6): 2601 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo and D. Eisenberg The Mechanism of the Amyloidogenic Conversion of T7 Endonuclease I J. Biol. Chem., May 18, 2007; 282(20): 14968 - 14974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lindman, W.-F. Xue, O. Szczepankiewicz, M. C. Bauer, H. Nilsson, and S. Linse Salting the Charged Surface: pH and Salt Dependence of Protein G B1 Stability Biophys. J., April 15, 2006; 90(8): 2911 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hortschansky, V. Schroeckh, T. Christopeit, G. Zandomeneghi, and M. Fandrich The aggregation kinetics of Alzheimer's {beta}-amyloid peptide is controlled by stochastic nucleation Protein Sci., July 1, 2005; 14(7): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. M. Chow, A. M. Ellisdon, L. D. Cabrita, and S. P. Bottomley Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein Stability: IMPLICATIONS FOR MISFOLDING AND DISEASE J. Biol. Chem., November 12, 2004; 279(46): 47643 - 47651. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Stathopulos, G. A. Scholz, Y.-M. Hwang, J. A.O. Rumfeldt, J. R. Lepock, and E. M. Meiering Sonication of proteins causes formation of aggregates that resemble amyloid Protein Sci., November 1, 2004; 13(11): 3017 - 3027. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |